Sequent Scientific Limited operates as an integrated pharmaceutical company in India, Europe, rest of Asia, and internationally. The company offers animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, antibacterial, anthelmintics, anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also provides analytical solutions, including method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. The ISIN of this stock is INE807F01027.